Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Palliative radiotherapy for symptomatic hepatocellular carcinoma improves survival in HCC or liver metastases

ASCO GI 2023

19 - 21 Jan 2023

Published: 7 Feb 2023

Views: 100

Rating:

Save

Prof Laura Dawson - University of Toronto, Toronto, Canada

Prof Laura Dawson speaks to ecancer about a phase III study of palliative radiotherapy for symptomatic hepatocellular carcinoma and liver metastases.

The trial investigated if more patients with painful liver cancer have improved pain 1 month following radiation therapy, compared to best supportive care (BSC).

The study found that single fraction RT improves hepatic pain in the majority of patients with end-stage HCC or liver metastases, with a trend to improved survival.

Related Videos

Twice-daily chemoradiation remains the standard of care in limited stage small...

Dr Gerard Walls - Queen's University Belfast, Belfast, Northern Ireland

Twice-daily chemoradiation remains the standard of care in limited stage small-cell lung cancer ( Dr Gerard Walls - Queen's University Belfast, Belfast, Northern Ireland )

Multiple myeloma in a resource constrained setting

Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda

Multiple myeloma in a resource constrained setting ( Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda )

Haemato-oncological Cancers

Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India

Haemato-oncological Cancers ( Dr Nikita Mehra - Cancer Institute (WIA), Chennai, India )

Multiple myeloma (A cancer arising from plasma cells)

Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal

Multiple myeloma (A cancer arising from plasma cells) ( Dr Nikesh Bajracharya - Civil Service Hospital, Kathmandu, Nepal )

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic...

Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City...

First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer ( Prof Eileen M O’Reilly - Memorial Sloan Kettering Cancer Center, New York City, USA )

Choosing Wisely in radiology

Dr Iramu Revelian - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in radiology ( Dr Iramu Revelian - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

Longest follow-up of patients with early breast cancer shows radiotherapy does...

Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK

Longest follow-up of patients with early breast cancer shows radiotherapy does not improve survival after 30 years ( Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK )

Perioperative nivolumab did not improve RFS in RCC patients at high risk for...

Dr Mohamad Allaf - The Johns Hopkins Hospital, Baltimore, USA

Perioperative nivolumab did not improve RFS in RCC patients at high risk for recurrence ( Dr Mohamad Allaf - The Johns Hopkins Hospital, Baltimore, USA )

More from ecancer